Prime Medicine, Inc.

US$4.65As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PRMEHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (29.36%)
Div yield —
ROE (373.29%)
Biotechnology
Beta (5Y) 2.15
PE TTM —
TSR TTM (5.87%)
Mkt cap US$827.3M
ROIC (73.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.75
2.10%
(94.43%)
Hold 5|11|4|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.09
0.09
17.05%
15.53%
3.73%
(1.03%)
Revenue$M
39.44
39.14
38.73
40.15
10.84%
5.23%
(0.64%)
(1.22%)
Peers (US$827.3M)
Cap (US$)
PE
822.8M
197.9x
Capital
TTM
5Y
10Y
Leveragex
0.995
0.020
0.017
EBIT/Intx
1.077
0.424
0.321
Own earn%
72.77
18.08
16.60
Sh yield%
43.58
32.87
32.24
Owners
Insiders/Inst%
6.61
54.03
Short interest%
4.41
SBC / revenue%
0.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
1–10
$1 testx
0.2
Incr. ROIC%
36